KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Liabilities and Shareholders Equity (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Liabilities and Shareholders Equity for 7 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 1.15% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 billion through Dec 2025, down 5.8% year-over-year, with the annual reading at $1.4 billion for FY2025, 1.15% up from the prior year.
  • Liabilities and Shareholders Equity hit $1.4 billion in Q4 2025 for GoodRx Holdings, up from $1.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.7 billion in Q3 2023 to a low of $1.3 billion in Q1 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $1.5 billion across 5 years, with a median of $1.6 billion in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 9.35% in 2021 and later decreased 20.68% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $1.6 billion in 2021, then dropped by 0.19% to $1.6 billion in 2022, then fell by 0.99% to $1.6 billion in 2023, then fell by 12.63% to $1.4 billion in 2024, then increased by 1.15% to $1.4 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for GDRX at $1.4 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.